» Articles » PMID: 28861522

A Serendipitous Mutation Reveals the Severe Virulence Defect of a Mutant

Overview
Journal mSphere
Date 2017 Sep 2
PMID 28861522
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

is considered a significant public health threat because of the emergence of multidrug-resistant strains and the challenge associated with treating life-threatening infections. Capsule, siderophores, and adhesins have been implicated as virulence determinants of , yet we lack a clear understanding of how this pathogen causes disease. In a previous screen for virulence genes, we identified a potential new virulence locus and constructed a mutant () with this locus deleted. In this study, we characterize the mutant and show that this mutation renders avirulent in a pneumonia model of infection. The mutant was expected to have a deletion of three genes, but subsequent genome sequencing indicated that a much larger deletion had occurred. Further analysis of the deleted region indicated that the virulence defect of the mutant could be attributed to the loss of FepB, a periplasmic protein required for import of the siderophore enterobactin. Interestingly, a Δ mutant was more attenuated than a mutant unable to synthesize enterobactin, suggesting that additional processes are affected. As FepB is highly conserved among the members of the family , therapeutic targeting of FepB may be useful for the treatment of and other bacterial infections. In addition to having a reputation as the causative agent of several types of hospital-acquired infections, has gained widespread attention as a pathogen with a propensity for acquiring antibiotic resistance. It is capable of causing a range of infections, including urinary tract infections, pneumonia, and sepsis. Because of the rapid emergence of carbapenem resistance among strains, there is a dire need for a better understanding of virulence mechanisms and identification of new drug targets. Here, we identify the periplasmic transporter FepB as one such potential target.

Citing Articles

Klebsiella pneumoniae employs a type VI secretion system to overcome microbiota-mediated colonization resistance.

Bray A, Broberg C, Hudson A, Wu W, Nagpal R, Islam M Nat Commun. 2025; 16(1):940.

PMID: 39843522 PMC: 11754592. DOI: 10.1038/s41467-025-56309-8.


Shedding light on Klebsiella pneumoniae virulence: Engineering of broad host range bioluminescence reporter vectors for transcriptional analysis in drug resistant pathogens.

Chandrashekarappa D, Van Allen M, Bina X, Bina J Plasmid. 2024; 131-132:102734.

PMID: 39481464 PMC: 11788892. DOI: 10.1016/j.plasmid.2024.102734.


An Enteric Bacterial Infection Triggers Neuroinflammation and Neurobehavioral Impairment in 3xTg-AD Transgenic Mice.

Park G, Kadyan S, Hochuli N, Salazar G, Laitano O, Chakrabarty P J Infect Dis. 2024; 230(Supplement_2):S95-S108.

PMID: 39255397 PMC: 11385593. DOI: 10.1093/infdis/jiae165.


Bacteraemia associated with multiple septic localizations caused by Klebsiella pneumoniae sequence type ST660.

Jauvain M, Carrer M, Palma F, Chapuzet C, Courat N, Heslan C Eur J Clin Microbiol Infect Dis. 2024; 43(8):1655-1659.

PMID: 38869685 DOI: 10.1007/s10096-024-04870-3.


Commensal E. coli limits Salmonella gut invasion during inflammation by producing toxin-bound siderophores in a tonB-dependent manner.

Cherrak Y, Salazar M, Yilmaz K, Kreuzer M, Hardt W PLoS Biol. 2024; 22(6):e3002616.

PMID: 38865418 PMC: 11168627. DOI: 10.1371/journal.pbio.3002616.


References
1.
Sprencel C, Cao Z, Qi Z, Scott D, Montague M, Ivanoff N . Binding of ferric enterobactin by the Escherichia coli periplasmic protein FepB. J Bacteriol. 2000; 182(19):5359-64. PMC: 110977. DOI: 10.1128/JB.182.19.5359-5364.2000. View

2.
George A, Hall R, Stokes H . Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli. Microbiology (Reading). 1995; 141 ( Pt 8):1909-1920. DOI: 10.1099/13500872-141-8-1909. View

3.
Mathers A, Peirano G, Pitout J . The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae. Clin Microbiol Rev. 2015; 28(3):565-91. PMC: 4405625. DOI: 10.1128/CMR.00116-14. View

4.
Ruzin A, Visalli M, Keeney D, Bradford P . Influence of transcriptional activator RamA on expression of multidrug efflux pump AcrAB and tigecycline susceptibility in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2005; 49(3):1017-22. PMC: 549240. DOI: 10.1128/AAC.49.3.1017-1022.2005. View

5.
Paczosa M, Mecsas J . Klebsiella pneumoniae: Going on the Offense with a Strong Defense. Microbiol Mol Biol Rev. 2016; 80(3):629-61. PMC: 4981674. DOI: 10.1128/MMBR.00078-15. View